Surveillance For Adverse Events After COVID-19 mRNA Vaccination

This journal article addresses safety concerns related to the administration of COVID-19 mRNA vaccines. It also discusses surveillance procedure and coordination of data collection and analysis capacity for public safety.

Related Topics

Disease Tracking and Surveillance

Disease surveillance helps us detect disease cases, understand burden of disease and risk factors, provide the basis for timely and informed decision-making, guide control measures, and monitor impacts. Since the onset of COVID-19, surveillance efforts have worked to provide real-time tracking and forecast data, despite challenges with diagnostic capacity, case reporting, insufficient contact tracing, and fragmented data systems. COVID-19 has highlighted the need to invest in modern data systems, expand and skill up the workforce, and ensure data reporting and interpretation retain high ethical and epidemiological standards.

Vaccination

Vaccination is one of public health’s most successful tools for preventing and controlling the spread of infectious diseases and, increasingly, cancers and chronic diseases too. Immunization is an effective and cost-efficient strategy that prevents sickness and death in all age groups and saves billions of dollars each year. The COVID-19 epidemic and recent outbreaks of measles and other preventable infectious diseases underscore the importance of vaccines and sustaining high vaccination rates. Work is needed to ensure that people of all ages receive a complete series of the vaccines they need.

Skip to content